000 | 01178 a2200301 4500 | ||
---|---|---|---|
005 | 20250514230059.0 | ||
264 | 0 | _c20050929 | |
008 | 200509s 0 0 eng d | ||
022 | _a0163-4356 | ||
024 | 7 |
_a10.1097/01.ftd.0000158081.38330.5e _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Jonge, Milly E | |
245 | 0 | 0 |
_aSparse sampling design for therapeutic drug monitoring of sequentially administered cyclophosphamide, thiotepa, and carboplatin (CTC). _h[electronic resource] |
260 |
_bTherapeutic drug monitoring _cJun 2005 |
||
300 |
_a393-402 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xblood |
650 | 0 | 4 |
_aCarboplatin _xblood |
650 | 0 | 4 |
_aCyclophosphamide _xblood |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aThiotepa _xblood |
700 | 1 | _aHuitema, Alwin D R | |
700 | 1 | _aRodenhuis, Sjoerd | |
700 | 1 | _aBeijnen, Jos H | |
773 | 0 |
_tTherapeutic drug monitoring _gvol. 27 _gno. 3 _gp. 393-402 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.ftd.0000158081.38330.5e _zAvailable from publisher's website |
999 |
_c15567837 _d15567837 |